BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 22987617)

  • 1. Identification of upregulated genes in oral squamous cell carcinomas.
    Lessa RC; Campos AH; Freitas CE; Silva FR; Kowalski LP; Carvalho AL; Vettore AL
    Head Neck; 2013 Oct; 35(10):1475-81. PubMed ID: 22987617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased mitochondrial copy numbers in oral squamous cell carcinoma.
    Takeda D; Hasegawa T; Ueha T; Sakakibara A; Kawamoto T; Minamikawa T; Sakai Y; Komori T
    Head Neck; 2016 Aug; 38(8):1170-5. PubMed ID: 27079936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Oct3/4 and Nanog in the head and neck squamous carcinoma cells and its clinical implications for delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma.
    Habu N; Imanishi Y; Kameyama K; Shimoda M; Tokumaru Y; Sakamoto K; Fujii R; Shigetomi S; Otsuka K; Sato Y; Watanabe Y; Ozawa H; Tomita T; Fujii M; Ogawa K
    BMC Cancer; 2015 Oct; 15():730. PubMed ID: 26483189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
    Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
    Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression profiling of head and neck squamous cell carcinoma using cDNA microarrays.
    Gottschlich S; Ambrosch P; Cordes C; Görögh T; Schreiber S; Häsler R
    Int J Oncol; 2006 Sep; 29(3):605-13. PubMed ID: 16865276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating multiple microarray datasets on oral squamous cell carcinoma to reveal dysregulated networks.
    Liu Z; Niu Y; Li C; Yang Y; Gao C
    Head Neck; 2012 Dec; 34(12):1789-97. PubMed ID: 22179951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating miRNAs as biomarkers for oral squamous cell carcinoma recurrence in operated patients.
    Yan Y; Wang X; Venø MT; Bakholdt V; Sørensen JA; Krogdahl A; Sun Z; Gao S; Kjems J
    Oncotarget; 2017 Jan; 8(5):8206-8214. PubMed ID: 28030794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in silico validation of CA3 and FHL1 downregulation in oral cancer.
    Pereira CM; de Carvalho AC; da Silva FR; Melendez ME; Lessa RC; Andrade VCC; Kowalski LP; Vettore AL; Carvalho AL
    BMC Cancer; 2018 Feb; 18(1):193. PubMed ID: 29454310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of insulin-like growth factor II mRNA-binding protein 3 in squamous cell carcinomas of the head and neck.
    Clauditz TS; Wang CJ; Gontarewicz A; Blessmann M; Tennstedt P; Borgmann K; Tribius S; Sauter G; Dalchow C; Knecht R; Münscher A; Wilczak W
    J Oral Pathol Med; 2013 Feb; 42(2):125-32. PubMed ID: 22643116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-B-crystallin expression in human laryngeal squamous cell carcinoma tissues.
    Yilmaz M; Karatas OF; Yuceturk B; Dag H; Yener M; Ozen M
    Head Neck; 2015 Sep; 37(9):1344-8. PubMed ID: 24817638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased expression of cell adhesion genes in cancer stem-like cells isolated from primary oral squamous cell carcinomas.
    Mishra A; Sriram H; Chandarana P; Tanavde V; Kumar RV; Gopinath A; Govindarajan R; Ramaswamy S; Sadasivam S
    Tumour Biol; 2018 May; 40(5):1010428318780859. PubMed ID: 29888653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Her2 expression and gene amplification is rarely detectable in patients with oral squamous cell carcinomas.
    Hanken H; Gaudin R; Gröbe A; Fraederich M; Eichhorn W; Smeets R; Simon R; Sauter G; Grupp K; Izbicki JR; Sehner S; Heiland M; Blessmann M
    J Oral Pathol Med; 2014 Apr; 43(4):304-8. PubMed ID: 24645976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer.
    Namani A; Matiur Rahaman M; Chen M; Tang X
    BMC Cancer; 2018 Jan; 18(1):46. PubMed ID: 29306329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Stem Cell Factor HMGA2 Is Expressed in Non-HPV-Associated Head and Neck Squamous Cell Carcinoma and Predicts Patient Survival of Distinct Subsites.
    Günther K; Foraita R; Friemel J; Günther F; Bullerdiek J; Nimzyk R; Markowski DN; Behrens T; Ahrens W
    Cancer Epidemiol Biomarkers Prev; 2017 Feb; 26(2):197-205. PubMed ID: 27742669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Illumina whole-genome complementary DNA-mediated annealing, selection, extension and ligation platform: assessing its performance in formalin-fixed, paraffin-embedded samples and identifying invasion pattern-related genes in oral squamous cell carcinoma.
    Loudig O; Brandwein-Gensler M; Kim RS; Lin J; Isayeva T; Liu C; Segall JE; Kenny PA; Prystowsky MB
    Hum Pathol; 2011 Dec; 42(12):1911-22. PubMed ID: 21683979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of cancer testis antigens in head and neck squamous cell carcinomas.
    Figueiredo DL; Mamede RC; Proto-Siqueira R; Neder L; Silva WA; Zago MA
    Head Neck; 2006 Jul; 28(7):614-9. PubMed ID: 16475205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulated expression of ADAM12 is associated with progression of oral squamous cell carcinoma.
    Uehara E; Shiiba M; Shinozuka K; Saito K; Kouzu Y; Koike H; Kasamatsu A; Sakamoto Y; Ogawara K; Uzawa K; Tanzawa H
    Int J Oncol; 2012 May; 40(5):1414-22. PubMed ID: 22267082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.
    Jensen DH; Dabelsteen E; Specht L; Fiehn AM; Therkildsen MH; Jønson L; Vikesaa J; Nielsen FC; von Buchwald C
    J Pathol; 2015 Aug; 236(4):505-16. PubMed ID: 25925492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative expression analysis of the apoptosis-related gene, BCL2L12, in head and neck squamous cell carcinoma.
    Geomela PA; Kontos CK; Yiotakis I; Scorilas A
    J Oral Pathol Med; 2013 Feb; 42(2):154-61. PubMed ID: 22747515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re-expression of Lactotransferrin, a candidate tumor suppressor inactivated by promoter hypermethylation, impairs the malignance of oral squamous cell carcinoma cells.
    Zhang J; Ling T; Wu H; Wang K
    J Oral Pathol Med; 2015 Sep; 44(8):578-84. PubMed ID: 25370482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.